Dianthus Therapeutics, Inc.

DNTHNasdaqCIK 1690585HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 154 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Dianthus Therapeutics, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-05-2708:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-21-174353
2021-05-1216:31 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-159128
2021-05-0608:15 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001193125-21-152654
2021-05-0608:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-152648
2021-04-2108:00 ET	DEF 14A	Proxy statementPeriod 2021-06-01	0001193125-21-123656
2021-03-0308:23 ET	10-K	Annual reportPeriod 2020-12-31	0001193125-21-066707
2021-03-0308:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-066691
2021-02-1708:26 ET	SC 13D/A	Ownership report, active investor, amended	0001387131-21-002579
2021-01-1108:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-005827
2020-12-2316:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-20-326001
2020-11-0908:18 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-20-288547
2020-11-0508:20 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001193125-20-286283
2020-11-0508:18 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-286280
2020-10-0216:29 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-20-262538
2020-09-0216:05 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-20-238147
2020-08-0608:20 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001193125-20-211380
2020-08-0608:14 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-211372
2020-07-1416:34 ET	SC 13D	Ownership report, active investor	0001387131-20-006396
2020-06-3008:14 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-183376
2020-06-3008:14 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-183374
2020-06-0916:17 ET	8-K	5.07 Shareholder vote results	0001193125-20-164669
2020-05-0707:42 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001193125-20-135615
2020-05-0707:38 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-135611
2020-04-2408:00 ET	DEF 14A	Proxy statementPeriod 2020-06-05	0001193125-20-118192
2020-04-1716:28 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-110697
2020-04-1616:48 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-109392
2020-03-0308:21 ET	10-K	Annual reportPeriod 2019-12-31	0001193125-20-059835
2020-03-0308:18 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-059812
2020-01-1308:16 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-005958
2019-11-1308:27 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001193125-19-290577
2019-11-1308:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-290573
2019-08-0808:16 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001193125-19-216106
2019-08-0808:13 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-216099
2019-06-2416:48 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-19-180195
2019-06-1116:43 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001193125-19-170256
2019-05-0908:11 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001193125-19-142296
2019-05-0908:09 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-142288
2019-05-0616:50 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-19-138390
2019-04-2916:09 ET	S-1	Registration statement	0001193125-19-125154
2019-04-2516:26 ET	DEF 14A	Proxy statementPeriod 2019-06-07	0001193125-19-119735
2019-03-1907:44 ET	10-K	Annual reportPeriod 2018-12-31	0001193125-19-078948
2019-03-1907:40 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-078945
2019-01-2416:15 ET	8-K	8.01 Other events	0001193125-19-015933
2019-01-0707:30 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-19-003130
2018-11-1916:10 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-18-330256
2018-11-0808:20 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001193125-18-321954
2018-11-0808:13 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-321948
2018-08-0916:21 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001193125-18-244360
2018-08-0916:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-244347
2018-06-2516:49 ET	8-K	5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-18-202570

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:21 ET. Listed shows no prices and gives no investment advice.